img

Global Fulvestrant Injection Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Fulvestrant Injection Market Insights, Forecast to 2034

Global Fulvestrant Injection market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Fulvestrant Injection industry is evaluated to reach US$ million in 2034. The CAGR will be % during 2024 to 2034.
Globally, Fulvestrant Injection key manufacturers include AstraZeneca, Sichuan Huiyu Pharmaceutical Co., Ltd., Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Corporation, Hansoh Pharmaceutical Group Company Limited, Qilu Pharmaceutical, Vetter Pharma-Fertigung GmbH & Co. KG, Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. and Sandoz, etc. AstraZeneca, Sichuan Huiyu Pharmaceutical Co., Ltd., Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Fulvestrant Injection were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034 and the sales share will be % in 2034. Moreover, China, plays a key role in the whole Fulvestrant Injection market and estimated to attract more attentions from industry insiders and investors.
Fulvestrant Injection can be divided into Original Drugs and Generic Drugs, etc. Original Drugs is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2034.
Fulvestrant Injection is widely used in various fields, such as Hospital, Clinic and Other,, etc. Hospital provides greatest supports to the Fulvestrant Injection industry development. In 2022, global % sales of Fulvestrant Injection went into Hospital filed and the proportion will reach to % in 2034.
Report Covers
This report presents an overview of global Fulvestrant Injection market from 2024 to 2034, aiming to help readers to get a comprehensive understanding of global Fulvestrant Injection market with multiple angles. Items like regional sales, revenue from 2024 to 2034 and manufacturers’ sales, price, revenue and gross margin from 2024 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2024 to 2034 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AstraZeneca
Sichuan Huiyu Pharmaceutical Co., Ltd.
Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
Lunan Pharmaceutical Group Corporation
Hansoh Pharmaceutical Group Company Limited
Qilu Pharmaceutical
Vetter Pharma-Fertigung GmbH & Co. KG
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
Sandoz
Hikma Pharmaceuticals
Teva Pharmaceuticals
Eugia US
Xiromed LLC
Segment by Type
Original Drugs
Generic Drugs

Segment by Application


Hospital
Clinic
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2024 to 2034
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Fulvestrant Injection plant distribution, commercial date of Fulvestrant Injection, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2024 to 2034 globally
Chapter 5Product sales, revenue and price analysis by application from 2024 to 2034 globally
Chapter 6Product sales, revenue analysis by type and application from 2024 to 2034 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2024 to 2034
Chapter 7Product sales, revenue analysis by type and application from 2024 to 2034 in Europe. Product sales and revenue analysis of each country in Europe from 2024 to 2034
Chapter 8Product sales, revenue analysis by type and application from 2024 to 2034 in China. Product sales and revenue analysis of China from 2024 to 2034
Chapter 9Product sales, revenue analysis by type and application from 2024 to 2034 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2024 to 2034
Chapter 10Product sales, revenue analysis by type and application from 2024 to 2034 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2024 to 2034.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Fulvestrant Injection introduction, etc. Fulvestrant Injection Sales, Revenue, Price and Gross Margin of each company from 2024 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Fulvestrant Injection
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Fulvestrant Injection Product Introduction
1.2 Market by Type
1.2.1 Global Fulvestrant Injection Market Size Growth Rate by Type, 2024 VS 2022 VS 2034
1.2.2 Original Drugs
1.2.3 Generic Drugs
1.3 Market by Application
1.3.1 Global Fulvestrant Injection Market Size Growth Rate by Application, 2024 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Fulvestrant Injection Sales Estimates and Forecasts 2024-2034
2.2 Global Fulvestrant Injection Revenue by Region
2.2.1 Global Fulvestrant Injection Revenue by Region: 2024 VS 2022 VS 2034
2.2.2 Global Fulvestrant Injection Revenue by Region (2024-2024)
2.2.3 Global Fulvestrant Injection Revenue by Region (2024-2034)
2.2.4 Global Fulvestrant Injection Revenue Market Share by Region (2024-2034)
2.3 Global Fulvestrant Injection Sales Estimates and Forecasts 2024-2034
2.4 Global Fulvestrant Injection Sales by Region
2.4.1 Global Fulvestrant Injection Sales by Region: 2024 VS 2022 VS 2034
2.4.2 Global Fulvestrant Injection Sales by Region (2024-2024)
2.4.3 Global Fulvestrant Injection Sales by Region (2024-2034)
2.4.4 Global Fulvestrant Injection Sales Market Share by Region (2024-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Fulvestrant Injection Sales by Manufacturers
3.1.1 Global Fulvestrant Injection Sales by Manufacturers (2024-2024)
3.1.2 Global Fulvestrant Injection Sales Market Share by Manufacturers (2024-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Fulvestrant Injection in 2022
3.2 Global Fulvestrant Injection Revenue by Manufacturers
3.2.1 Global Fulvestrant Injection Revenue by Manufacturers (2024-2024)
3.2.2 Global Fulvestrant Injection Revenue Market Share by Manufacturers (2024-2024)
3.2.3 Global Top 10 and Top 5 Companies by Fulvestrant Injection Revenue in 2022
3.3 Global Key Players of Fulvestrant Injection, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Fulvestrant Injection Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Fulvestrant Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Fulvestrant Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Fulvestrant Injection, Product Offered and Application
3.8 Global Key Manufacturers of Fulvestrant Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Fulvestrant Injection Sales by Type
4.1.1 Global Fulvestrant Injection Historical Sales by Type (2024-2024)
4.1.2 Global Fulvestrant Injection Forecasted Sales by Type (2024-2034)
4.1.3 Global Fulvestrant Injection Sales Market Share by Type (2024-2034)
4.2 Global Fulvestrant Injection Revenue by Type
4.2.1 Global Fulvestrant Injection Historical Revenue by Type (2024-2024)
4.2.2 Global Fulvestrant Injection Forecasted Revenue by Type (2024-2034)
4.2.3 Global Fulvestrant Injection Revenue Market Share by Type (2024-2034)
4.3 Global Fulvestrant Injection Price by Type
4.3.1 Global Fulvestrant Injection Price by Type (2024-2024)
4.3.2 Global Fulvestrant Injection Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Fulvestrant Injection Sales by Application
5.1.1 Global Fulvestrant Injection Historical Sales by Application (2024-2024)
5.1.2 Global Fulvestrant Injection Forecasted Sales by Application (2024-2034)
5.1.3 Global Fulvestrant Injection Sales Market Share by Application (2024-2034)
5.2 Global Fulvestrant Injection Revenue by Application
5.2.1 Global Fulvestrant Injection Historical Revenue by Application (2024-2024)
5.2.2 Global Fulvestrant Injection Forecasted Revenue by Application (2024-2034)
5.2.3 Global Fulvestrant Injection Revenue Market Share by Application (2024-2034)
5.3 Global Fulvestrant Injection Price by Application
5.3.1 Global Fulvestrant Injection Price by Application (2024-2024)
5.3.2 Global Fulvestrant Injection Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Fulvestrant Injection Market Size by Type
6.1.1 US & Canada Fulvestrant Injection Sales by Type (2024-2034)
6.1.2 US & Canada Fulvestrant Injection Revenue by Type (2024-2034)
6.2 US & Canada Fulvestrant Injection Market Size by Application
6.2.1 US & Canada Fulvestrant Injection Sales by Application (2024-2034)
6.2.2 US & Canada Fulvestrant Injection Revenue by Application (2024-2034)
6.3 US & Canada Fulvestrant Injection Market Size by Country
6.3.1 US & Canada Fulvestrant Injection Revenue by Country: 2024 VS 2022 VS 2034
6.3.2 US & Canada Fulvestrant Injection Sales by Country (2024-2034)
6.3.3 US & Canada Fulvestrant Injection Revenue by Country (2024-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Fulvestrant Injection Market Size by Type
7.1.1 Europe Fulvestrant Injection Sales by Type (2024-2034)
7.1.2 Europe Fulvestrant Injection Revenue by Type (2024-2034)
7.2 Europe Fulvestrant Injection Market Size by Application
7.2.1 Europe Fulvestrant Injection Sales by Application (2024-2034)
7.2.2 Europe Fulvestrant Injection Revenue by Application (2024-2034)
7.3 Europe Fulvestrant Injection Market Size by Country
7.3.1 Europe Fulvestrant Injection Revenue by Country: 2024 VS 2022 VS 2034
7.3.2 Europe Fulvestrant Injection Sales by Country (2024-2034)
7.3.3 Europe Fulvestrant Injection Revenue by Country (2024-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Fulvestrant Injection Market Size
8.1.1 China Fulvestrant Injection Sales (2024-2034)
8.1.2 China Fulvestrant Injection Revenue (2024-2034)
8.2 China Fulvestrant Injection Market Size by Application
8.2.1 China Fulvestrant Injection Sales by Application (2024-2034)
8.2.2 China Fulvestrant Injection Revenue by Application (2024-2034)
9 Asia (excluding China)
9.1 Asia Fulvestrant Injection Market Size by Type
9.1.1 Asia Fulvestrant Injection Sales by Type (2024-2034)
9.1.2 Asia Fulvestrant Injection Revenue by Type (2024-2034)
9.2 Asia Fulvestrant Injection Market Size by Application
9.2.1 Asia Fulvestrant Injection Sales by Application (2024-2034)
9.2.2 Asia Fulvestrant Injection Revenue by Application (2024-2034)
9.3 Asia Fulvestrant Injection Sales by Region
9.3.1 Asia Fulvestrant Injection Revenue by Region: 2024 VS 2022 VS 2034
9.3.2 Asia Fulvestrant Injection Revenue by Region (2024-2034)
9.3.3 Asia Fulvestrant Injection Sales by Region (2024-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Fulvestrant Injection Market Size by Type
10.1.1 Middle East, Africa and Latin America Fulvestrant Injection Sales by Type (2024-2034)
10.1.2 Middle East, Africa and Latin America Fulvestrant Injection Revenue by Type (2024-2034)
10.2 Middle East, Africa and Latin America Fulvestrant Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America Fulvestrant Injection Sales by Application (2024-2034)
10.2.2 Middle East, Africa and Latin America Fulvestrant Injection Revenue by Application (2024-2034)
10.3 Middle East, Africa and Latin America Fulvestrant Injection Sales by Country
10.3.1 Middle East, Africa and Latin America Fulvestrant Injection Revenue by Country: 2024 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Fulvestrant Injection Revenue by Country (2024-2034)
10.3.3 Middle East, Africa and Latin America Fulvestrant Injection Sales by Country (2024-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Fulvestrant Injection Sales, Price, Revenue and Gross Margin (2024-2024)
11.1.4 AstraZeneca Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 Sichuan Huiyu Pharmaceutical Co., Ltd.
11.2.1 Sichuan Huiyu Pharmaceutical Co., Ltd. Company Information
11.2.2 Sichuan Huiyu Pharmaceutical Co., Ltd. Overview
11.2.3 Sichuan Huiyu Pharmaceutical Co., Ltd. Fulvestrant Injection Sales, Price, Revenue and Gross Margin (2024-2024)
11.2.4 Sichuan Huiyu Pharmaceutical Co., Ltd. Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sichuan Huiyu Pharmaceutical Co., Ltd. Recent Developments
11.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
11.3.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Company Information
11.3.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Overview
11.3.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Fulvestrant Injection Sales, Price, Revenue and Gross Margin (2024-2024)
11.3.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Recent Developments
11.4 Lunan Pharmaceutical Group Corporation
11.4.1 Lunan Pharmaceutical Group Corporation Company Information
11.4.2 Lunan Pharmaceutical Group Corporation Overview
11.4.3 Lunan Pharmaceutical Group Corporation Fulvestrant Injection Sales, Price, Revenue and Gross Margin (2024-2024)
11.4.4 Lunan Pharmaceutical Group Corporation Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lunan Pharmaceutical Group Corporation Recent Developments
11.5 Hansoh Pharmaceutical Group Company Limited
11.5.1 Hansoh Pharmaceutical Group Company Limited Company Information
11.5.2 Hansoh Pharmaceutical Group Company Limited Overview
11.5.3 Hansoh Pharmaceutical Group Company Limited Fulvestrant Injection Sales, Price, Revenue and Gross Margin (2024-2024)
11.5.4 Hansoh Pharmaceutical Group Company Limited Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hansoh Pharmaceutical Group Company Limited Recent Developments
11.6 Qilu Pharmaceutical
11.6.1 Qilu Pharmaceutical Company Information
11.6.2 Qilu Pharmaceutical Overview
11.6.3 Qilu Pharmaceutical Fulvestrant Injection Sales, Price, Revenue and Gross Margin (2024-2024)
11.6.4 Qilu Pharmaceutical Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Qilu Pharmaceutical Recent Developments
11.7 Vetter Pharma-Fertigung GmbH & Co. KG
11.7.1 Vetter Pharma-Fertigung GmbH & Co. KG Company Information
11.7.2 Vetter Pharma-Fertigung GmbH & Co. KG Overview
11.7.3 Vetter Pharma-Fertigung GmbH & Co. KG Fulvestrant Injection Sales, Price, Revenue and Gross Margin (2024-2024)
11.7.4 Vetter Pharma-Fertigung GmbH & Co. KG Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Vetter Pharma-Fertigung GmbH & Co. KG Recent Developments
11.8 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
11.8.1 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Company Information
11.8.2 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Overview
11.8.3 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Fulvestrant Injection Sales, Price, Revenue and Gross Margin (2024-2024)
11.8.4 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Recent Developments
11.9 Sandoz
11.9.1 Sandoz Company Information
11.9.2 Sandoz Overview
11.9.3 Sandoz Fulvestrant Injection Sales, Price, Revenue and Gross Margin (2024-2024)
11.9.4 Sandoz Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sandoz Recent Developments
11.10 Hikma Pharmaceuticals
11.10.1 Hikma Pharmaceuticals Company Information
11.10.2 Hikma Pharmaceuticals Overview
11.10.3 Hikma Pharmaceuticals Fulvestrant Injection Sales, Price, Revenue and Gross Margin (2024-2024)
11.10.4 Hikma Pharmaceuticals Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Hikma Pharmaceuticals Recent Developments
11.11 Teva Pharmaceuticals
11.11.1 Teva Pharmaceuticals Company Information
11.11.2 Teva Pharmaceuticals Overview
11.11.3 Teva Pharmaceuticals Fulvestrant Injection Sales, Price, Revenue and Gross Margin (2024-2024)
11.11.4 Teva Pharmaceuticals Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Teva Pharmaceuticals Recent Developments
11.12 Eugia US
11.12.1 Eugia US Company Information
11.12.2 Eugia US Overview
11.12.3 Eugia US Fulvestrant Injection Sales, Price, Revenue and Gross Margin (2024-2024)
11.12.4 Eugia US Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Eugia US Recent Developments
11.13 Xiromed LLC
11.13.1 Xiromed LLC Company Information
11.13.2 Xiromed LLC Overview
11.13.3 Xiromed LLC Fulvestrant Injection Sales, Price, Revenue and Gross Margin (2024-2024)
11.13.4 Xiromed LLC Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Xiromed LLC Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Fulvestrant Injection Industry Chain Analysis
12.2 Fulvestrant Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Fulvestrant Injection Production Mode & Process
12.4 Fulvestrant Injection Sales and Marketing
12.4.1 Fulvestrant Injection Sales Channels
12.4.2 Fulvestrant Injection Distributors
12.5 Fulvestrant Injection Customers
13 Market Dynamics
13.1 Fulvestrant Injection Industry Trends
13.2 Fulvestrant Injection Market Drivers
13.3 Fulvestrant Injection Market Challenges
13.4 Fulvestrant Injection Market Restraints
14 Key Findings in The Global Fulvestrant Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Fulvestrant Injection Market Size Growth Rate by Type, 2024 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Original Drugs
Table 3. Major Manufacturers of Generic Drugs
Table 4. Global Fulvestrant Injection Market Size Growth Rate by Application, 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global Fulvestrant Injection Revenue Grow Rate (CAGR) by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Fulvestrant Injection Revenue by Region (2024-2024) & (US$ Million)
Table 7. Global Fulvestrant Injection Revenue by Region (2024-2034) & (US$ Million)
Table 8. Global Fulvestrant Injection Revenue Market Share by Region (2024-2024)
Table 9. Global Fulvestrant Injection Revenue Market Share by Region (2024-2034)
Table 10. Global Fulvestrant Injection Sales Grow Rate (CAGR) by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 11. Global Fulvestrant Injection Sales by Region (2024-2024) & (K Units)
Table 12. Global Fulvestrant Injection Sales by Region (2024-2034) & (K Units)
Table 13. Global Fulvestrant Injection Sales Market Share by Region (2024-2024)
Table 14. Global Fulvestrant Injection Sales Market Share by Region (2024-2034)
Table 15. Global Fulvestrant Injection Sales by Manufacturers (2024-2024) & (K Units)
Table 16. Global Fulvestrant Injection Sales Share by Manufacturers (2024-2024)
Table 17. Global Fulvestrant Injection Revenue by Manufacturers (2024-2024) & (US$ Million)
Table 18. Global Fulvestrant Injection Revenue Share by Manufacturers (2024-2024)
Table 19. Global Key Players of Fulvestrant Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Fulvestrant Injection Price by Manufacturers 2024-2024 (US$/Unit)
Table 21. Global Fulvestrant Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Fulvestrant Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fulvestrant Injection as of 2022)
Table 23. Global Key Manufacturers of Fulvestrant Injection, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Fulvestrant Injection, Product Offered and Application
Table 25. Global Key Manufacturers of Fulvestrant Injection, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Fulvestrant Injection Sales by Type (2024-2024) & (K Units)
Table 28. Global Fulvestrant Injection Sales by Type (2024-2034) & (K Units)
Table 29. Global Fulvestrant Injection Sales Share by Type (2024-2024)
Table 30. Global Fulvestrant Injection Sales Share by Type (2024-2034)
Table 31. Global Fulvestrant Injection Revenue by Type (2024-2024) & (US$ Million)
Table 32. Global Fulvestrant Injection Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Fulvestrant Injection Revenue Share by Type (2024-2024)
Table 34. Global Fulvestrant Injection Revenue Share by Type (2024-2034)
Table 35. Fulvestrant Injection Price by Type (2024-2024) & (US$/Unit)
Table 36. Global Fulvestrant Injection Price Forecast by Type (2024-2034) & (US$/Unit)
Table 37. Global Fulvestrant Injection Sales by Application (2024-2024) & (K Units)
Table 38. Global Fulvestrant Injection Sales by Application (2024-2034) & (K Units)
Table 39. Global Fulvestrant Injection Sales Share by Application (2024-2024)
Table 40. Global Fulvestrant Injection Sales Share by Application (2024-2034)
Table 41. Global Fulvestrant Injection Revenue by Application (2024-2024) & (US$ Million)
Table 42. Global Fulvestrant Injection Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Fulvestrant Injection Revenue Share by Application (2024-2024)
Table 44. Global Fulvestrant Injection Revenue Share by Application (2024-2034)
Table 45. Fulvestrant Injection Price by Application (2024-2024) & (US$/Unit)
Table 46. Global Fulvestrant Injection Price Forecast by Application (2024-2034) & (US$/Unit)
Table 47. US & Canada Fulvestrant Injection Sales by Type (2024-2024) & (K Units)
Table 48. US & Canada Fulvestrant Injection Sales by Type (2024-2034) & (K Units)
Table 49. US & Canada Fulvestrant Injection Revenue by Type (2024-2024) & (US$ Million)
Table 50. US & Canada Fulvestrant Injection Revenue by Type (2024-2034) & (US$ Million)
Table 51. US & Canada Fulvestrant Injection Sales by Application (2024-2024) & (K Units)
Table 52. US & Canada Fulvestrant Injection Sales by Application (2024-2034) & (K Units)
Table 53. US & Canada Fulvestrant Injection Revenue by Application (2024-2024) & (US$ Million)
Table 54. US & Canada Fulvestrant Injection Revenue by Application (2024-2034) & (US$ Million)
Table 55. US & Canada Fulvestrant Injection Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 56. US & Canada Fulvestrant Injection Revenue by Country (2024-2024) & (US$ Million)
Table 57. US & Canada Fulvestrant Injection Revenue by Country (2024-2034) & (US$ Million)
Table 58. US & Canada Fulvestrant Injection Sales by Country (2024-2024) & (K Units)
Table 59. US & Canada Fulvestrant Injection Sales by Country (2024-2034) & (K Units)
Table 60. Europe Fulvestrant Injection Sales by Type (2024-2024) & (K Units)
Table 61. Europe Fulvestrant Injection Sales by Type (2024-2034) & (K Units)
Table 62. Europe Fulvestrant Injection Revenue by Type (2024-2024) & (US$ Million)
Table 63. Europe Fulvestrant Injection Revenue by Type (2024-2034) & (US$ Million)
Table 64. Europe Fulvestrant Injection Sales by Application (2024-2024) & (K Units)
Table 65. Europe Fulvestrant Injection Sales by Application (2024-2034) & (K Units)
Table 66. Europe Fulvestrant Injection Revenue by Application (2024-2024) & (US$ Million)
Table 67. Europe Fulvestrant Injection Revenue by Application (2024-2034) & (US$ Million)
Table 68. Europe Fulvestrant Injection Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 69. Europe Fulvestrant Injection Revenue by Country (2024-2024) & (US$ Million)
Table 70. Europe Fulvestrant Injection Revenue by Country (2024-2034) & (US$ Million)
Table 71. Europe Fulvestrant Injection Sales by Country (2024-2024) & (K Units)
Table 72. Europe Fulvestrant Injection Sales by Country (2024-2034) & (K Units)
Table 73. China Fulvestrant Injection Sales by Type (2024-2024) & (K Units)
Table 74. China Fulvestrant Injection Sales by Type (2024-2034) & (K Units)
Table 75. China Fulvestrant Injection Revenue by Type (2024-2024) & (US$ Million)
Table 76. China Fulvestrant Injection Revenue by Type (2024-2034) & (US$ Million)
Table 77. China Fulvestrant Injection Sales by Application (2024-2024) & (K Units)
Table 78. China Fulvestrant Injection Sales by Application (2024-2034) & (K Units)
Table 79. China Fulvestrant Injection Revenue by Application (2024-2024) & (US$ Million)
Table 80. China Fulvestrant Injection Revenue by Application (2024-2034) & (US$ Million)
Table 81. Asia Fulvestrant Injection Sales by Type (2024-2024) & (K Units)
Table 82. Asia Fulvestrant Injection Sales by Type (2024-2034) & (K Units)
Table 83. Asia Fulvestrant Injection Revenue by Type (2024-2024) & (US$ Million)
Table 84. Asia Fulvestrant Injection Revenue by Type (2024-2034) & (US$ Million)
Table 85. Asia Fulvestrant Injection Sales by Application (2024-2024) & (K Units)
Table 86. Asia Fulvestrant Injection Sales by Application (2024-2034) & (K Units)
Table 87. Asia Fulvestrant Injection Revenue by Application (2024-2024) & (US$ Million)
Table 88. Asia Fulvestrant Injection Revenue by Application (2024-2034) & (US$ Million)
Table 89. Asia Fulvestrant Injection Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 90. Asia Fulvestrant Injection Revenue by Region (2024-2024) & (US$ Million)
Table 91. Asia Fulvestrant Injection Revenue by Region (2024-2034) & (US$ Million)
Table 92. Asia Fulvestrant Injection Sales by Region (2024-2024) & (K Units)
Table 93. Asia Fulvestrant Injection Sales by Region (2024-2034) & (K Units)
Table 94. Middle East, Africa and Latin America Fulvestrant Injection Sales by Type (2024-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Fulvestrant Injection Sales by Type (2024-2034) & (K Units)
Table 96. Middle East, Africa and Latin America Fulvestrant Injection Revenue by Type (2024-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Fulvestrant Injection Revenue by Type (2024-2034) & (US$ Million)
Table 98. Middle East, Africa and Latin America Fulvestrant Injection Sales by Application (2024-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Fulvestrant Injection Sales by Application (2024-2034) & (K Units)
Table 100. Middle East, Africa and Latin America Fulvestrant Injection Revenue by Application (2024-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Fulvestrant Injection Revenue by Application (2024-2034) & (US$ Million)
Table 102. Middle East, Africa and Latin America Fulvestrant Injection Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 103. Middle East, Africa and Latin America Fulvestrant Injection Revenue by Country (2024-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Fulvestrant Injection Revenue by Country (2024-2034) & (US$ Million)
Table 105. Middle East, Africa and Latin America Fulvestrant Injection Sales by Country (2024-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Fulvestrant Injection Sales by Country (2024-2034) & (K Units)
Table 107. AstraZeneca Company Information
Table 108. AstraZeneca Description and Major Businesses
Table 109. AstraZeneca Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. AstraZeneca Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. AstraZeneca Recent Developments
Table 112. Sichuan Huiyu Pharmaceutical Co., Ltd. Company Information
Table 113. Sichuan Huiyu Pharmaceutical Co., Ltd. Description and Major Businesses
Table 114. Sichuan Huiyu Pharmaceutical Co., Ltd. Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Sichuan Huiyu Pharmaceutical Co., Ltd. Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Sichuan Huiyu Pharmaceutical Co., Ltd. Recent Developments
Table 117. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Company Information
Table 118. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Description and Major Businesses
Table 119. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Recent Developments
Table 122. Lunan Pharmaceutical Group Corporation Company Information
Table 123. Lunan Pharmaceutical Group Corporation Description and Major Businesses
Table 124. Lunan Pharmaceutical Group Corporation Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Lunan Pharmaceutical Group Corporation Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Lunan Pharmaceutical Group Corporation Recent Developments
Table 127. Hansoh Pharmaceutical Group Company Limited Company Information
Table 128. Hansoh Pharmaceutical Group Company Limited Description and Major Businesses
Table 129. Hansoh Pharmaceutical Group Company Limited Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Hansoh Pharmaceutical Group Company Limited Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Hansoh Pharmaceutical Group Company Limited Recent Developments
Table 132. Qilu Pharmaceutical Company Information
Table 133. Qilu Pharmaceutical Description and Major Businesses
Table 134. Qilu Pharmaceutical Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Qilu Pharmaceutical Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Qilu Pharmaceutical Recent Developments
Table 137. Vetter Pharma-Fertigung GmbH & Co. KG Company Information
Table 138. Vetter Pharma-Fertigung GmbH & Co. KG Description and Major Businesses
Table 139. Vetter Pharma-Fertigung GmbH & Co. KG Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Vetter Pharma-Fertigung GmbH & Co. KG Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Vetter Pharma-Fertigung GmbH & Co. KG Recent Developments
Table 142. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Company Information
Table 143. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Description and Major Businesses
Table 144. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Recent Developments
Table 147. Sandoz Company Information
Table 148. Sandoz Description and Major Businesses
Table 149. Sandoz Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Sandoz Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Sandoz Recent Developments
Table 152. Hikma Pharmaceuticals Company Information
Table 153. Hikma Pharmaceuticals Description and Major Businesses
Table 154. Hikma Pharmaceuticals Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Hikma Pharmaceuticals Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Hikma Pharmaceuticals Recent Developments
Table 157. Teva Pharmaceuticals Company Information
Table 158. Teva Pharmaceuticals Description and Major Businesses
Table 159. Teva Pharmaceuticals Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. Teva Pharmaceuticals Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Teva Pharmaceuticals Recent Developments
Table 162. Eugia US Company Information
Table 163. Eugia US Description and Major Businesses
Table 164. Eugia US Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. Eugia US Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Eugia US Recent Developments
Table 167. Xiromed LLC Company Information
Table 168. Xiromed LLC Description and Major Businesses
Table 169. Xiromed LLC Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 170. Xiromed LLC Fulvestrant Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Xiromed LLC Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Fulvestrant Injection Distributors List
Table 175. Fulvestrant Injection Customers List
Table 176. Fulvestrant Injection Market Trends
Table 177. Fulvestrant Injection Market Drivers
Table 178. Fulvestrant Injection Market Challenges
Table 179. Fulvestrant Injection Market Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Fulvestrant Injection Product Picture
Figure 2. Global Fulvestrant Injection Market Size Growth Rate by Type, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Fulvestrant Injection Market Share by Type in 2022 & 2034
Figure 4. Original Drugs Product Picture
Figure 5. Generic Drugs Product Picture
Figure 6. Global Fulvestrant Injection Market Size Growth Rate by Application, 2024 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Fulvestrant Injection Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Fulvestrant Injection Report Years Considered
Figure 12. Global Fulvestrant Injection Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 13. Global Fulvestrant Injection Revenue 2024-2034 (US$ Million)
Figure 14. Global Fulvestrant Injection Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global Fulvestrant Injection Revenue Market Share by Region (2024-2034)
Figure 16. Global Fulvestrant Injection Sales 2024-2034 ((K Units)
Figure 17. Global Fulvestrant Injection Sales Market Share by Region (2024-2034)
Figure 18. US & Canada Fulvestrant Injection Sales YoY (2024-2034) & (K Units)
Figure 19. US & Canada Fulvestrant Injection Revenue YoY (2024-2034) & (US$ Million)
Figure 20. Europe Fulvestrant Injection Sales YoY (2024-2034) & (K Units)
Figure 21. Europe Fulvestrant Injection Revenue YoY (2024-2034) & (US$ Million)
Figure 22. China Fulvestrant Injection Sales YoY (2024-2034) & (K Units)
Figure 23. China Fulvestrant Injection Revenue YoY (2024-2034) & (US$ Million)
Figure 24. Asia (excluding China) Fulvestrant Injection Sales YoY (2024-2034) & (K Units)
Figure 25. Asia (excluding China) Fulvestrant Injection Revenue YoY (2024-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Fulvestrant Injection Sales YoY (2024-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Fulvestrant Injection Revenue YoY (2024-2034) & (US$ Million)
Figure 28. The Fulvestrant Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Fulvestrant Injection in the World: Market Share by Fulvestrant Injection Revenue in 2022
Figure 30. Global Fulvestrant Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 31. Global Fulvestrant Injection Sales Market Share by Type (2024-2034)
Figure 32. Global Fulvestrant Injection Revenue Market Share by Type (2024-2034)
Figure 33. Global Fulvestrant Injection Sales Market Share by Application (2024-2034)
Figure 34. Global Fulvestrant Injection Revenue Market Share by Application (2024-2034)
Figure 35. US & Canada Fulvestrant Injection Sales Market Share by Type (2024-2034)
Figure 36. US & Canada Fulvestrant Injection Revenue Market Share by Type (2024-2034)
Figure 37. US & Canada Fulvestrant Injection Sales Market Share by Application (2024-2034)
Figure 38. US & Canada Fulvestrant Injection Revenue Market Share by Application (2024-2034)
Figure 39. US & Canada Fulvestrant Injection Revenue Share by Country (2024-2034)
Figure 40. US & Canada Fulvestrant Injection Sales Share by Country (2024-2034)
Figure 41. U.S. Fulvestrant Injection Revenue (2024-2034) & (US$ Million)
Figure 42. Canada Fulvestrant Injection Revenue (2024-2034) & (US$ Million)
Figure 43. Europe Fulvestrant Injection Sales Market Share by Type (2024-2034)
Figure 44. Europe Fulvestrant Injection Revenue Market Share by Type (2024-2034)
Figure 45. Europe Fulvestrant Injection Sales Market Share by Application (2024-2034)
Figure 46. Europe Fulvestrant Injection Revenue Market Share by Application (2024-2034)
Figure 47. Europe Fulvestrant Injection Revenue Share by Country (2024-2034)
Figure 48. Europe Fulvestrant Injection Sales Share by Country (2024-2034)
Figure 49. Germany Fulvestrant Injection Revenue (2024-2034) & (US$ Million)
Figure 50. France Fulvestrant Injection Revenue (2024-2034) & (US$ Million)
Figure 51. U.K. Fulvestrant Injection Revenue (2024-2034) & (US$ Million)
Figure 52. Italy Fulvestrant Injection Revenue (2024-2034) & (US$ Million)
Figure 53. Russia Fulvestrant Injection Revenue (2024-2034) & (US$ Million)
Figure 54. China Fulvestrant Injection Sales Market Share by Type (2024-2034)
Figure 55. China Fulvestrant Injection Revenue Market Share by Type (2024-2034)
Figure 56. China Fulvestrant Injection Sales Market Share by Application (2024-2034)
Figure 57. China Fulvestrant Injection Revenue Market Share by Application (2024-2034)
Figure 58. Asia Fulvestrant Injection Sales Market Share by Type (2024-2034)
Figure 59. Asia Fulvestrant Injection Revenue Market Share by Type (2024-2034)
Figure 60. Asia Fulvestrant Injection Sales Market Share by Application (2024-2034)
Figure 61. Asia Fulvestrant Injection Revenue Market Share by Application (2024-2034)
Figure 62. Asia Fulvestrant Injection Revenue Share by Region (2024-2034)
Figure 63. Asia Fulvestrant Injection Sales Share by Region (2024-2034)
Figure 64. Japan Fulvestrant Injection Revenue (2024-2034) & (US$ Million)
Figure 65. South Korea Fulvestrant Injection Revenue (2024-2034) & (US$ Million)
Figure 66. China Taiwan Fulvestrant Injection Revenue (2024-2034) & (US$ Million)
Figure 67. Southeast Asia Fulvestrant Injection Revenue (2024-2034) & (US$ Million)
Figure 68. India Fulvestrant Injection Revenue (2024-2034) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Fulvestrant Injection Sales Market Share by Type (2024-2034)
Figure 70. Middle East, Africa and Latin America Fulvestrant Injection Revenue Market Share by Type (2024-2034)
Figure 71. Middle East, Africa and Latin America Fulvestrant Injection Sales Market Share by Application (2024-2034)
Figure 72. Middle East, Africa and Latin America Fulvestrant Injection Revenue Market Share by Application (2024-2034)
Figure 73. Middle East, Africa and Latin America Fulvestrant Injection Revenue Share by Country (2024-2034)
Figure 74. Middle East, Africa and Latin America Fulvestrant Injection Sales Share by Country (2024-2034)
Figure 75. Brazil Fulvestrant Injection Revenue (2024-2034) & (US$ Million)
Figure 76. Mexico Fulvestrant Injection Revenue (2024-2034) & (US$ Million)
Figure 77. Turkey Fulvestrant Injection Revenue (2024-2034) & (US$ Million)
Figure 78. Israel Fulvestrant Injection Revenue (2024-2034) & (US$ Million)
Figure 79. GCC Countries Fulvestrant Injection Revenue (2024-2034) & (US$ Million)
Figure 80. Fulvestrant Injection Value Chain
Figure 81. Fulvestrant Injection Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed